Cargando…

Antimetastatic activity of novel ruthenium (III) pyridine complexes

Ruthenium‐based complexes have emerged as promising anticancer, especially antimetastatic agents. Among them, NAMI‐A (trans‐[Ru(III)Cl(4) (DMSO)(Im)][ImH], Im = imidazole, DMSO = dimethyl sulfoxide) was well studied. In this study, we studied the antimetastatic activities of two novel NAMI‐A derivat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Liwei, Li, Xiaodong, Ran, Qingsen, Kang, Chen, Lee, Canghai, Shen, Jianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083739/ https://www.ncbi.nlm.nih.gov/pubmed/27605356 http://dx.doi.org/10.1002/cam4.826

Ejemplares similares

Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
por: Schmieder, Roberta, et al.
Publicado: (2014)

IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
por: Desbois, Mélanie, et al.
Publicado: (2020)

Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier
por: Tran, Ngoc Lan, et al.
Publicado: (2022)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes
por: Ma, Wenli, et al.
Publicado: (2019)

Synthesis and Structures of Ruthenium Carbonyl Complexes Bearing Pyridine-Alkoxide Ligands and Their Catalytic Activity in Alcohol Oxidation
por: Yan, Xinlong, et al.
Publicado: (2019)

Impact of Polypyridyl Ru Complexes on Angiogenesis—Contribution to Their Antimetastatic Activity
por: Gurgul, Ilona, et al.
Publicado: (2022)

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
por: Messori, L., et al.
Publicado: (2000)

Effective models for antimetastatic therapies
por: Tian, Lin, et al.
Publicado: (2017)

Novel Unsymmetrical Ru(III) and Mixed-valence Ru(III)/Ru(II) Dinuclear Compounds Related to the Antimetastatic Ru(III) Drug NAMI-A
por: Serli, B., et al.
Publicado: (2001)

Antimetastatic activity of a cyclooxygenase-2 inhibitor
por: Roche-Nagle, G, et al.
Publicado: (2004)

trans-Dibromidotetrakis(pyridine-κN)ruthenium(II)
por: Wu, Xiu-Li, et al.
Publicado: (2013)

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
por: Riccardi, Claudia, et al.
Publicado: (2019)

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer
por: Iskar, Murat, et al.
Publicado: (2015)

Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

Development and Application of Ruthenium(II) and Iridium(III) Based Complexes for Anion Sensing
por: Rashid, Ambreen, et al.
Publicado: (2023)

Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers
por: Davoodvandi, Amirhossein, et al.
Publicado: (2021)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

Antitumor and antimetastatic activity of interleukin 12 against murine tumors
Publicado: (1993)

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018)

Antimetastatic activity of seongsanamide B in γ-irradiated human lung cancer
por: Ryoo, Ga-Hee, et al.
Publicado: (2023)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

The Ruthenium Nitrosyl Moiety in Clusters: Trinuclear Linear μ-Hydroxido Magnesium(II)-Diruthenium(II), μ(3)-Oxido Trinuclear Diiron(III)–Ruthenium(II), and Tetranuclear μ(4)-Oxido Trigallium(III)-Ruthenium(II) Complexes
por: Stepanenko, Iryna, et al.
Publicado: (2021)

Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties
por: Mestroni, G., et al.
Publicado: (1994)

Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo
por: Ho, Mao-Lin, et al.
Publicado: (2011)

Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
por: Lu, Da-Yong, et al.
Publicado: (2012)

In Vitro and In Vivo Antimetastatic Effect of Glutathione Disulfide Liposomes
por: Sadhu, Satya S, et al.
Publicado: (2017)

Oxidative Stress and Antimicrobial Activity of Chromium(III) and Ruthenium(II) Complexes on Staphylococcus aureus and Escherichia coli
por: Páez, Paulina L., et al.
Publicado: (2013)

Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
por: Elsayed, Shadia A., et al.
Publicado: (2020)

Special Issue on Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2017)

Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells
por: Dalla Pozza, Maria, et al.
Publicado: (2021)

Antimetastatic Activity of Polymeric RGDT Peptides Conjugated with Poly(ethylene glycol)
por: Saiki, Ikuo, et al.
Publicado: (1993)

A Review of the Structure—Activity Relationship of Natural and Synthetic Antimetastatic Compounds
por: Liew, Su Ki, et al.
Publicado: (2020)

Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy
por: Jayakumar, Thanasekaran, et al.
Publicado: (2018)

Biological Activities of Ruthenium NHC Complexes: An Update
por: Catalano, Alessia, et al.
Publicado: (2023)

Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated‐mAb directed against cancer/testis antigens 83
por: Ye, Ziyu, et al.
Publicado: (2018)

Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis
por: Li, Juan, et al.
Publicado: (2021)

Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide
por: Abebe, Atakilt, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pnomfr0rlol0q65vpdf2b0gtps